Poirrier JE, DeMartino JK, Nagar S, Carrico J, Hicks K, Meyers J, Stoddard J. Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination. Hum Vaccin Immunother. 2022 Nov;18(5):2040328. doi: 10.1080/21645515.2022.2040328
Poirrier J-E, Carrico J, DeMartino JK, Hicks KA, Stoddard JJ, Nagar S, Meyers J. The potential for reducing opioid and analgesic prescriptions via herpes zoster vaccination. Poster presented at the IDWeek 2020 Virtual Conference; October 21, 2020.
Filonenko A, Purser M, Mader G, Graham J. Impact of increased utilization of long-acting reversable contraceptive methods among young women on cost and unintended pregnancies (UP) in the United States (US). Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S153. doi: 10.1016/j.jval.2020.04.371
Parikh RC, Nagar SP, Ajmera M, Kurosky SK. Nationwide trends in prescription opioid use among adults- a pre-public health emergency perspective on the opioid crisis. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
Sura SD, Goyal RK, Adhikari D, Mehta HB. Association of multiple chronic conditions with health-related quality of life and physical functioning. Poster presented at the 2017 ISPOR 20th Annual European Congress; November 7, 2017. Glasgow, Scotland.
Goyal RK, Ajmera MR, Davis KL. Recent trends in emergency department visits resulting from unintentional overdose of non-opioid analgesics, antipyretics, and antirheumatics in the United States. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A231.
Cairns B, Kowolenko M, Talbird S, Britt T, Shanley L. Applying artificial intelligence to the diagnosis of rare diseases. Presented at the UNC Renaissance Computing Institute (RENCI); February 15, 2017. Chapel Hill, NC.
Boscarino JA, Kirchner HL, Pitcavage JM, Nadipelli VR, Ronquest NA, Fitzpatrick MH, Han JJ. Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system. Subst Abuse Rehabil. 2016 Sep 16;7:131-41. doi: 10.2147/SAR.S108302
Boscarino JA, Kirchner HL, Pitcavage JM, Nadipelli VR, Ronquest NA, Fitzpatrick MH. A 10 year retrospective study of opioid overdoses among patients in a large integrated healthcare system. Poster presented at the 2016 International Conference on Opioids Conference; June 2016. Boston, MA.
Gold R, Esterberg E, Hollombe C, Arkind J, Vakarcs PA, Tran H, Burdick T, Devoe JE, Horberg MA. Low back imaging when not indicated: a descriptive cross-system analysis. Perm J. 2016;20(2):25-33. doi: 10.7812/TPP/15-08
Du XL, Parikh RC, Lairson DR. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007–2010 after the 2006 introduction of bevacizumab. Lung Cancer. 2015 Dec;90(3):442-50.
Partha G, Gupta S, Bhattacharyya S, Halliday A, McBride D, Graham J, Balp MM, Marsland A. Adapting literature-based remission rates for chronic spontaneous/idiopathic urticaria to the needs of a health economic model: a Kaplan-Meier approach. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Hicks KA, Bowers LD. A model for developing athlete testing strategies based on the costs and benefits of doping. Presented at the 14th Annual USADA Symposium on Anti-Doping Science; October 4, 2015. Leesburg, VA.
Mladsi D, Ramamohan V, Ronquest N, Boklage SH. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among SIADH patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S33.
Brown JP, Amaechi BT, Bader JD, Shugars D, Vollmer WM, Chen C, Gilbert GH, Esterberg EJ, X-ACT Collaborative Research Group. The dynamic behavior of the early dental caries lesion in caries-active adults and implications. Community Dent Oral Epidemiol. 2015 Jun;43(3):208-16. doi: 10.1111/cdoe.12143
Reese ES, Kurosky SK, Candrilli S. Recent trends in urgent antibacterial threat-related hospitalization in the US. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A234-5.
Meyers JL, Candrilli SD. Common reasons for and associated burden of inpatient admissions among children in the United States. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A252-3.
Walker A, Berling M, Malmenas M, Brodtkorb T, Alvarez-Reyes M. Estimation of time to reach RRMS EDSS health states >= 7.0 or SPMS for delayed-release dimethyl fumarate. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Candrilli SD, Blackwood J. The association between the nature and timing of dental visits and c-reactive protein levels. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.
Hawe E, Stull DE, McBride D, Balp M. Estimating utility data for patient symptom severity in chronic spontaneous urticaria. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, the Netherlands.
Sikirica V, Bapat B, Candrilli SD, Davis KL, Wilson M, Johns A. The inpatient burden of abdominal and gynecological adhesiolysis in the US. BMC Surg. 2011 Jun 1;11:13.
Stull DE, Houghton KF, Wesnes K. Little or no treatment effect? Application of growth mixture models to explore unknown subgroups of differential responders to treatment. Presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD.
Mauskopf J, Chirila C, Masaquel CJ, Boye KS, Bowman L, Birt J, Grainger DB. The relationship between financial impact and the likelihood of drug reimbursement in the Australian health care system. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 26, 2011. [abstract] Value Health. 2011 May; 14(3):A22-3.
Barnett C, Muckstadt JA. Using simulation to assess public health emergency distribution networks: the emergency supply chain operations evaluator (ESCOE). Presented at the INFORMS Annual Meeting 2010; November 2010. Austin, TX.
Candrilli SD, Kuznik A, Mendys PM, Wilson DJ. Prevalence and coexistence of cardiovascular comorbidities among the US dyslipidemic population aged [greater than or equal to] 65 years by lipid-lowering medication use status. Postgrad Med. 2010 Sep 1;122(5):142-9.
Grogan S, Hartley L, Fry G, Conner M, Gough B. Appearance concerns and smoking in young men and women: going beyond weight control. Drug-Educ Prev Polic. 2010 May 6;17(3):261-9. doi: 10.3109/09687630802422019
Gonzalez-Rojas N, Vieta A, Monreal M, Wolowacz SE. Economic analysis of dabigatran etexilate for the primary prevention of venous thromboembolism following total hip or knee replacement in Spain. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 24, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A440.
Davis KL, Candrilli SD, Mitra D, Tortella BJ, Joshi AV. The effect of injury severity and trauma center designation on inpatient costs and outcomes in hospital admissions for traumatic injury in the United States. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland.
Candrilli S, Davis KL, Mitra D, Tortella BJ, Joshi AV. Inpatient costs and outcomes associated with traumatic injury in the United States by injury severity and trauma center designation. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A97.
Earnshaw SR, Brogan AJ. Markov-model toolkit: concepts and assumptions. Presented at the 19th Annual Meeting and Showcase of the Academy of Managed Care Pharmacy; April 2007. San Diego, CA.
Davis KL, Joshi AV, Tortella BJ, Candrilli SD. The direct economic burden of blunt and penetrating trauma in a managed care population. J Trauma. 2007 Mar 30;62(3):622-30.
Davis KL, Candrilli SD, Joshi AV, Tortella BJ. The direct economic burden of blunt and penetrating trauma among the elderly population. Poster presented at the Society of Critical Care Medicine’s (SCCM) 36th Critical Care Congress; February 22, 2007.
Candrilli SD, Davis KL, Joshi AV, Tortella BJ. Healthcare utilization and costs associated with blunt and penetrating trauma in a United States managed care population. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.
Davis KL, Joshi AV, Tortella BJ, Candrilli SD. The direct economic burden of blunt and penetrating trauma in a managed care population. Poster presented at the American Association for the Surgery of Trauma Annual Meeting; September 30, 2006. New Orleans, LA.
Earnshaw SR, Gricar J. Good practices for high quality decision analytic models. Poster presented at the Academy of Managed Care Pharmacy 18th Annual Meeting; April 6, 2006.
Tsianos G, Eleftheriou KI, Hawe E, Woolrich L, Watt M, Watt I, Peacock A, Montgomery H, Grant S. Performance at altitude and angiotensin I-converting enzyme genotype. Eur J Appl Physiol. 2005;93(5-6):630-3.
Curry SJ, Fiore MC, West R, Sullivan SD, Nonnemaker J, Neighbors D, Zhou X, Jourdan S, Brouard R. Preliminary data from assessment toward tobacco economical and medical prospective trial (ATTEMPT)—A global longitudinal cohort study of the natural history of quit attempts. Poster presented at the 10th Annual Scientific Sessions of the Society for Research on Nicotine and Tobacco; February 2004. Scottsdale, AZ.
Abeysinghe SS, Stenson PD PD, Krawczak M, Cooper DN DN. Gross Rearrangement Breakpoint Database (GRABDTM). Hum Mutat. 2004;23(3):219-21.
Bacolla A, Jaworski A, Larson JE, Jakupciak JP, Chuzhanova N, Abeysinghe SS, O'Connell CD, Cooper DN, Wells RD. Breakpoints of gross deletions coincide with non-B DNA conformations. Proc Natl Acad Sci U S A. 2004;101(39):14162-7.
Woods D, Sanders J, Jones A, Hawe E, Gohlke P, Humphries SE, Payne J, Montgomery H. The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype. Eur J Appl Physiol. 2004;91(2-3):342-8.
Manga N, Duffy JC, Rowe PH, Cronin MTD. A hierarchical QSAR model for urinary excretion of drugs in humans as a predictive tool for biotransformation. QSAR Comb Sci. 2003 Apr 17;22(2):263-73. doi: 10.1002/qsar.200390021
Cronin MT, Dearden JC, Duffy JC, Edwards R, Manga N, Worth AP, Worgan AD. The importance of hydrophobicity and electrophilicity descriptors in mechanistically-based QSARs for toxicological endpoints. SAR QSAR Environ Res. 2002 Mar;13(1):167-76.
Woods DR, Pollard AJ, Collier DJ, Jamshidi Y, Vassiliou V, Hawe E, Humphries SE, Montgomery HE. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med. 2002;166(3):362-6.
Dombeck M, Earnshaw SR, Candrilli SD, Xuan J, Bakst A, Kirsch JM. Modeling antibiotic efficacy by infectious agent and probability of resistance. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 4th Annual European Congress; November 2001. [abstract] Value Health. 2001 Sep; 4(6):427.
Smart JD, Nicholls TJ, Green KL, Rogers DJ, Cook JD, Wolowacz SE. Lectins in drug delivery: an in vivo toxicity study of the lectins from Solanum tuberosum and Helix pomatia. J Pharm Pharmacol. 1998 Sep.
Wolowacz SE, Yon Hin BFY, Lowe CR. Covalent electropolymerisation of glucose oxidase in polypyrrole. Anal Chem. 1992;64(14):1541.
Lowe CR, Foulds NC, Wolowacz SE, Yon Hin BFY. Enzyme entrapment in conducting polymers, application to amperometric biosensors. London: United Kingdom. Springer Series in Solid State Sciences; 1991.
Wolowacz SE, Yon Hin BFY, Lowe CR. Covalent electropolymerisation of glucose oxidase in polypyrrole. Poster presented at the 3rd International Conference of Chemical Sensors; 1990. Cleveland, OH.